Icure Pharmaceutical Incorporation - Asset Resilience Ratio

Latest as of March 2025: 5.45%

Icure Pharmaceutical Incorporation (175250) has an Asset Resilience Ratio of 5.45% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩6.75 Billion

≈ $4.57 Million USD Cash + Short-term Investments

Total Assets

₩123.73 Billion

≈ $83.85 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Icure Pharmaceutical Incorporation's Asset Resilience Ratio has changed over time. Check 175250 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Icure Pharmaceutical Incorporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Icure Pharmaceutical Incorporation market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩4.49 Billion	3.63%
Short-term Investments	₩2.25 Billion	1.82%
Total Liquid Assets	₩6.75 Billion	5.45%

Asset Resilience Insights

Limited Liquidity: Icure Pharmaceutical Incorporation maintains only 5.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Icure Pharmaceutical Incorporation Industry Peers by Asset Resilience Ratio

Compare Icure Pharmaceutical Incorporation's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Icure Pharmaceutical Incorporation (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Icure Pharmaceutical Incorporation.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	16.88%	₩22.44 Billion ≈ $15.20 Million	₩132.88 Billion ≈ $90.05 Million	+11.73pp
2023-12-31	5.15%	₩8.56 Billion ≈ $5.80 Million	₩166.14 Billion ≈ $112.59 Million	-18.85pp
2022-12-31	24.00%	₩53.79 Billion ≈ $36.45 Million	₩224.12 Billion ≈ $151.88 Million	+12.67pp
2021-12-31	11.33%	₩24.42 Billion ≈ $16.55 Million	₩215.45 Billion ≈ $146.01 Million	+4.30pp
2020-12-31	7.03%	₩13.72 Billion ≈ $9.30 Million	₩195.15 Billion ≈ $132.25 Million	-1.77pp
2019-12-31	8.80%	₩18.99 Billion ≈ $12.87 Million	₩215.80 Billion ≈ $146.24 Million	-19.97pp
2018-12-31	28.77%	₩34.81 Billion ≈ $23.59 Million	₩121.00 Billion ≈ $82.00 Million	+11.05pp
2017-12-31	17.72%	₩9.55 Billion ≈ $6.47 Million	₩53.90 Billion ≈ $36.53 Million	+14.35pp
2016-12-31	3.37%	₩1.06 Billion ≈ $720.17K	₩31.53 Billion ≈ $21.36 Million	--

pp = percentage points

About Icure Pharmaceutical Incorporation

KQ:175250 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$54.96 Million

₩81.09 Billion KRW

Market Cap Rank

#21486 Global

#1236 in Korea

Share Price

₩2170.00

Change (1 day)

+0.00%

52-Week Range

₩2170.00 - ₩2170.00

All Time High

₩23730.97